The FDA warns of serious health risks associated with non-medical use of nitrous oxide, highlighting neurological damage, thromboembolic events, and death.
Linpharma's Lyranda, a novel cold sore treatment available OTC, demonstrated a 5.7-fold increase in complete healing at 5 days compared to other therapies in clinical trials.